A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial.

MLA

Kubota, K., et al. “A Randomized Phase III Trial of Oral S-1 plus Cisplatin versus Docetaxel plus Cisplatin in Japanese Patients with Advanced Non-Small-Cell Lung Cancer: TCOG0701 CATS Trial.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 26, no. 7, July 2015, pp. 1401–08. EBSCOhost, https://doi.org/10.1093/annonc/mdv190.

APA

Kubota, K., Sakai, H., Katakami, N., Nishio, M., Inoue, A., Okamoto, H., Isobe, H., Kunitoh, H., Takiguchi, Y., Kobayashi, K., Nakamura, Y., Ohmatsu, H., Sugawara, S., Minato, K., Fukuda, M., Yokoyama, A., Takeuchi, M., Michimae, H., Gemma, A., & Kudoh, S. (2015). A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 26(7), 1401–1408. https://doi.org/10.1093/annonc/mdv190

Chicago

Kubota, K, H Sakai, N Katakami, M Nishio, A Inoue, H Okamoto, H Isobe, et al. 2015. “A Randomized Phase III Trial of Oral S-1 plus Cisplatin versus Docetaxel plus Cisplatin in Japanese Patients with Advanced Non-Small-Cell Lung Cancer: TCOG0701 CATS Trial.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 26 (7): 1401–8. doi:10.1093/annonc/mdv190.